-
Webinar: “Contributions from the gut-brain axis to neural inflammation in ALS”
Presentor: Kevin Eggan, Ph.D., GVP, Head of Research and Early Development for BioMarin Pharmaceutical Inc.
Scientific Luminary and MacArthur Fellowship winner, Kevin Eggan, Ph.D., is responsible for the execution of BioMarin’s discovery research programs, playing a critical role in shaping the vision of the company’s future research pipeline. Dr. Eggan has served as a tenured Professor in the Department of Stem Cell and Regenerative Biology at Harvard University, Director of Stem Cell Biology for the Stanley Center for Psychiatric Research at the Broad Institute, and as an Institute Member of the Broad Institute of MIT and Harvard. In addition, Dr. Eggan has published approximately 130 scientific articles and holds 13 patents.
July 14th 2021 at 4:00 pm PT
7:00pm ET, 6:00pm CT, 5:00 MT
To RSVP and obtain Zoom link CLICK HEREThis webinar will be recorded and posted HERE – 1 week following the presentation.
For our forum members:
– What would you ask Dr. Eggan about his topic?
– If you attended this webinar, what was your takeaway or the important points that you learned?
– Do you agree with Dr. Eggan? -
1 Reply
-
There are bizarre and interesting stories on this topic, for example the mice animal model of C9orf72 that dies quickly at Stanford but where perfectly healthy at MIT.
After investigating the matter, the scientists (including Dr. Eggan) found that the mice didn’t have the same gut microbiome.
https://www.alzforum.org/news/research-news/gut-microbes-difference-between-life-and-death-c9orf72-mice -
15 minutes to go.
Log in to reply.